|
Patient
|
Age (years)
|
Sex
|
Diagnosis
|
Max glucocorticoid (mg/day)a
|
Duration between the start of treatment and second CT (months)b
|
Dose of glucocorticoid at second CT (mg/day)
|
Cumulative doses of glucocorticoid (g)c,d
|
|---|
|
1
|
70
|
M
|
MCNS
|
PSL: 40
|
1.5
|
PSL: 25
|
PSL: 1.4
|
|
2
|
66
|
F
|
LN
|
mPSL → PSL: 35
|
2.5
|
PSL: 20
|
PSL: 2.4
|
|
3
|
46
|
F
|
LN
|
mPSL → mPSL: 32
|
3
|
mPSL: 12
|
PSL: 2.2
|
|
4
|
57
|
F
|
EPGA
|
mPSL → PSL: 50
|
3
|
PSL: 25
|
PSL: 3.4
|
|
5
|
80
|
M
|
MPA
|
mPSL → PSL: 30
|
2.5
|
PSL: 15
|
PSL: 1.3
|
|
6
|
86
|
F
|
MPA
|
mPSL → mPSL: 32
|
1.5
|
mPSL: 20
|
PSL: 1.5
|
|
7
|
79
|
F
|
MCNS
|
mPSL: 32
|
1.5
|
mPSL: 16 + PSL: 2
|
PSL: 1.6
|
|
8
|
76
|
F
|
HSPN
|
mPSL: 32
|
5.0
|
mPSL: 8
|
PSL: 2.6
|
- M male, F female, MCNS minimal change nephrotic syndrome, LN lupus nephritis, EPGA eosinophilic granulomatosis with polyangiitis, MPA microscopic polyangiitis, HSPN Henoch-Schönlein purpura nephritis, PSL prednisolone, mPSL methylprednisolone
- aInitial mPSL dose was 500 mg × 3 d, except for Patient 3 (1 g × 3 d) and Patients 7 and 8 (reported in table)
- bThe first CTs were performed within 6 weeks before the initial steroid therapy
- cSteroid taken using steroid pulse was excluded from cumulative doses of glucocorticoid
- dmPSL 0.8 mg is converted as PSL 1 mg
